By 2026, a doubling of hospital-at-home patients will propel a 55% growth in investments in tech-enabled integrated care initiatives to address patient safety, workforce, and care access concerns in Asia/Pacific (excluding Japan).
Personalized medicine backed by AI could be extremely beneficial for treating common diseases such as cancer or heart ailments or some rare ones like cystic fibrosis.
This breakthrough study demonstrates how the synergy of artificial intelligence and ambient light as a power source can enable the next generation of IoT devices.